Table 2.
Variable | Number of patients | Median DSS, months | P-value (univariate) | Median DFS, months | P-value (univariate) |
---|---|---|---|---|---|
Gender | |||||
Male | 14 | NR | 97 | ||
Female | 29 | NR | 0.457 | NR | 0.487 |
Age | |||||
<50 years | 16 | NR | NR | ||
≥50 years | 27 | NR | 0.896 | 97 | 0.400 |
Grade | |||||
Low | 19 | NR | NR | ||
Intermediate | 24 | NR | 0.244 | 97 | 0.091 |
Tumour size | |||||
<5 cm | 29 | NR | NR | ||
≥5 cm | 14 | 106 | 0.041 | 97 | 0.032 |
Tumour multifocality | |||||
Absent | 37 | NR | NR | ||
Present | 6 | 86 | 0.724 | 97 | 0.318 |
Margin | |||||
Negative | 36 | NR | NR | ||
Positive | 7 | 106 | 0.074 | 25 | <0.001 |
Nodal status | |||||
Negative | 25 | NR | NR | ||
Positive | 18 | NR | 0.486 | 46 | 0.007 |
Vascular invasion | |||||
Absent | 39 | NR | NR | ||
Present | 4 | NR | 0.038 | 38 | 0.349 |
Perineural invasion | |||||
Absent | 37 | NR | NR | ||
Present | 6 | NR | 0.422 | 25 | 0.014 |
Statistically significant values are shown in bold
DFS, disease-free survival; DSS, disease-specific survival; NR, not reached